Total Payments
$8,541
2023 Payments
$247.97
Companies
11
Transactions
61
Payment Breakdown by Category
Travel$3,483 (40.8%)
Research$3,136 (36.7%)
Food & Beverage$1,922 (22.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $3,483 | 14 | 40.8% |
| Unspecified | $3,136 | 1 | 36.7% |
| Food and Beverage | $1,922 | 46 | 22.5% |
Payments by Type
General
$5,405
60 transactions
Research
$3,136
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $3,825 | 36 | $0 (2023) |
| Eli Lilly and Company | $3,136 | 1 | $0 (2018) |
| Actelion Pharmaceuticals, Ltd | $955.40 | 7 | $0 (2018) |
| Actelion Clinical Research, Inc. | $288.51 | 3 | $0 (2018) |
| Novo Nordisk Inc | $121.97 | 1 | $0 (2023) |
| Gilead Sciences, Inc. | $111.60 | 6 | $0 (2019) |
| Medtronic Vascular, Inc. | $31.45 | 2 | $0 (2020) |
| Edwards Lifesciences Corporation | $26.31 | 2 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.25 | 1 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $15.11 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $247.97 | 2 | Actelion Pharmaceuticals US, Inc. ($126.00) |
| 2022 | $81.62 | 3 | Actelion Pharmaceuticals US, Inc. ($81.62) |
| 2021 | $103.11 | 5 | Actelion Pharmaceuticals US, Inc. ($89.74) |
| 2020 | $84.80 | 3 | Actelion Pharmaceuticals US, Inc. ($70.20) |
| 2019 | $60.58 | 4 | Gilead Sciences, Inc. ($34.27) |
| 2018 | $5,100 | 17 | Eli Lilly and Company ($3,136) |
| 2017 | $2,863 | 27 | Actelion Pharmaceuticals US, Inc. ($1,980) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $126.00 | General |
| Category: Cardiology | ||||||
| 05/24/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.97 | General |
| Category: Obesity | ||||||
| 05/23/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $33.52 | General |
| Category: Cardiology | ||||||
| 04/12/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $35.25 | General |
| Category: Cardiology | ||||||
| 03/01/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Cardiology | ||||||
| 11/15/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: Cardiology | ||||||
| 08/24/2021 | Medtronic, Inc. | Micra (Device) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Pacemakers | ||||||
| 07/19/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Cardiology | ||||||
| 06/15/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Cardiology | ||||||
| 01/04/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Cardiology | ||||||
| 08/11/2020 | Medtronic Vascular, Inc. | Azure (Device) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Pacemakers | ||||||
| 07/07/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $30.70 | General |
| Category: Cardiology | ||||||
| 02/11/2020 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $39.50 | General |
| Category: Cardiology | ||||||
| 11/20/2019 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $15.22 | General |
| 11/13/2019 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $11.09 | General |
| 06/03/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.19 | General |
| 01/15/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.08 | General |
| 12/01/2018 | Actelion Pharmaceuticals US, Inc. | — | Travel and Lodging | Cash or cash equivalent | $461.35 | General |
| 12/01/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $141.39 | General |
| 12/01/2018 | Actelion Pharmaceuticals US, Inc. | — | Travel and Lodging | Cash or cash equivalent | $139.31 | General |
| 12/01/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $109.97 | General |
| 12/01/2018 | Actelion Pharmaceuticals US, Inc. | — | Travel and Lodging | Cash or cash equivalent | $68.51 | General |
| 12/01/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $62.84 | General |
| 12/01/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $20.73 | General |
| 11/30/2018 | Actelion Pharmaceuticals US, Inc. | — | Travel and Lodging | Cash or cash equivalent | $347.89 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A DOUBLE-BLIND EFFICACY AND SAFETY STUDY OF THE PHOSPHODIESTERASE TYPE 5 INHIBITOR TADALAFIL IN PEDIATRIC PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION | Eli Lilly and Company | $3,136 | 1 |
About Dr. Robert Ross, MD
Dr. Robert Ross, MD is a Pediatrics healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770523235.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Ross, MD has received a total of $8,541 in payments from pharmaceutical and medical device companies, with $247.97 received in 2023. These payments were reported across 61 transactions from 11 companies. The most common payment nature is "Travel and Lodging" ($3,483).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Cardiology
- Location Detroit, MI
- Active Since 06/06/2006
- Last Updated 01/12/2017
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1770523235
Products in Payments
- CIALIS (Drug) $3,136
- OPSUMIT MACITENTAN (Drug) $703.26
- OPSUMIT (Drug) $336.86
- Wegovy (Drug) $121.97
- UPTRAVI (Drug) $30.70
- Advisa (Device) $16.85
- XIFAXAN (Drug) $16.25
- XIFAXANIBSD (Drug) $15.11
- Azure (Device) $14.60
- Micra (Device) $13.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Detroit
Thomas Forbes, Md, MD
Pediatrics — Payments: $1.1M
Pediatrics $1.1M
Meera Chitlur, Md, MD
Pediatrics — Payments: $265,159
Pediatrics $265,159
Gyula Acsadi, Md, MD
Pediatrics — Payments: $204,410
Pediatrics $204,410
Madhvi Rajpurkar, Md, MD
Pediatrics — Payments: $175,387
Pediatrics $175,387
Wanda Whitten-Shurney, Md, MD
Pediatrics — Payments: $138,965
Pediatrics $138,965
Ahmar Zaidi, M.d, M.D
Pediatrics — Payments: $128,594
Pediatrics $128,594